Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
20.06.25
/
50%
€32.00
Target price
20.06.26
€55.59
Performance (%)
-12.50%
Price
18.12.25
€28.00
Summary
This prediction is currently active. The price of Ultragenyx Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.50%. This prediction currently runs until 20.06.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -7.895% | -7.895% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $64.00 price target on the stock.
Ratings data for RARE provided by MarketBeat